rs139790943

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_020975.6(RET):​c.785T>C​(p.Val262Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000215 in 1,612,474 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V262M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 2 hom. )

Consequence

RET
NM_020975.6 missense

Scores

4
12
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:14B:9

Conservation

PhyloP100: 5.52

Publications

11 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020975.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23900184).
BP6
Variant 10-43105111-T-C is Benign according to our data. Variant chr10-43105111-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 41845.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000256 (39/152180) while in subpopulation AMR AF = 0.000457 (7/15302). AF 95% confidence interval is 0.000243. There are 0 homozygotes in GnomAd4. There are 22 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.785T>Cp.Val262Ala
missense
Exon 4 of 20NP_066124.1P07949-1
RET
NM_001406743.1
c.785T>Cp.Val262Ala
missense
Exon 4 of 21NP_001393672.1P07949-1
RET
NM_001406744.1
c.785T>Cp.Val262Ala
missense
Exon 4 of 20NP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.785T>Cp.Val262Ala
missense
Exon 4 of 20ENSP00000347942.3P07949-1
RET
ENST00000340058.6
TSL:1
c.785T>Cp.Val262Ala
missense
Exon 4 of 19ENSP00000344798.4P07949-2
RET
ENST00000713926.1
c.656T>Cp.Val219Ala
missense
Exon 4 of 19ENSP00000519223.1A0AAQ5BH28

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
152062
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000247
AC:
61
AN:
246512
AF XY:
0.000291
show subpopulations
Gnomad AFR exome
AF:
0.0000628
Gnomad AMR exome
AF:
0.0000872
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000967
Gnomad NFE exome
AF:
0.000325
Gnomad OTH exome
AF:
0.000827
GnomAD4 exome
AF:
0.000211
AC:
308
AN:
1460294
Hom.:
2
Cov.:
36
AF XY:
0.000222
AC XY:
161
AN XY:
726582
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33468
American (AMR)
AF:
0.0000895
AC:
4
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.000383
AC:
33
AN:
86238
European-Finnish (FIN)
AF:
0.0000383
AC:
2
AN:
52184
Middle Eastern (MID)
AF:
0.00626
AC:
36
AN:
5750
European-Non Finnish (NFE)
AF:
0.000184
AC:
205
AN:
1111832
Other (OTH)
AF:
0.000348
AC:
21
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152180
Hom.:
0
Cov.:
32
AF XY:
0.000296
AC XY:
22
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41526
American (AMR)
AF:
0.000457
AC:
7
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5130
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
67988
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000507
Hom.:
0
Bravo
AF:
0.000253
EpiCase
AF:
0.000491
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
2
not provided (5)
-
2
1
Hereditary cancer-predisposing syndrome (3)
-
1
2
Multiple endocrine neoplasia type 2A (3)
-
2
1
Multiple endocrine neoplasia, type 2 (3)
-
2
-
not specified (2)
-
1
-
Aganglionic megacolon (1)
-
1
-
Hirschsprung disease, susceptibility to, 1 (1)
-
1
-
Malignant tumor of breast (1)
-
-
1
Multiple endocrine neoplasia (1)
-
-
1
Pheochromocytoma (1)
-
1
-
Renal hypodysplasia/aplasia 1 (1)
-
-
1
RET-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.70
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.30
CADD
Pathogenic
30
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.75
D
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.22
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.81
T
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.24
T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.5
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-2.4
N
REVEL
Pathogenic
0.75
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.011
D
Varity_R
0.64
gMVP
0.94
Mutation Taster
=40/60
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs139790943;
hg19: chr10-43600559;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.